Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks - Rasul, Sazan; Hacker, Marcus; Kretschmer-Chott, Elisabeth; Leisser, Asha; Grubmüller, Bernhard; Kramer, Gero; Shariat, Shahrokh; Wadsak, Wolfgang; Mitterhauser, Markus; Hartenbach, Markus; Haug, Alexander R. (European journal of nuclear medicine and molecular imaging, 2020)
Keywords: Anemia; Cardiology; Castration; Hemoglobin; Imaging; Intervals; Leukocytes; Leukopenia; Lutetium isotopes; Medicine; Medicine & Public Health; Metastases; Metastasis; Nuclear Medicine; Oncology; Oncology – Genitourinary; Original; Original Article; Orthopedics; Patients; Platelets; Prostate cancer; Radiology; Receiving; Reduction; Statistical models; Survival; Therapy; Toxicity; mCRPC; PSMA PET; PSMA therapy; Prostate cancer; PSA response